H.C. Andersen Bio Pharma ApS: Financial statements 2021
CVR: 38683462
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
H.C. Andersen Bio Pharma ApS (CVR 38683462) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -5,351 and a net result of DKK -6,637 compared with DKK -111,890 the year before. Equity in the 2021 report amounted to DKK -287,672.
- Revenue
- DKK 0
- Gross Profit
- DKK -5,351
- Profit/Loss
- DKK -6,637
- Equity
- DKK -287,672
- Total Assets
- DKK 20,201
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -5 t. | -7 t. | -288 t. | - |
| 2020 | 2 t. | -111 t. | -112 t. | -281 t. | - |
| 2019 | - | -11 t. | -12 t. | -169 t. | - |
| 2018 | 0 | -190 t. | -191 t. | -157 t. | - |
Official annual report
Find more companies like H.C. Andersen Bio Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
H.C. Andersen Bio Pharma ApS has published its annual report for 2020. Revenue came to DKK 1,560, and the net result was DKK -111,890.
About H.C. Andersen Bio Pharma ApS
H.C. Andersen Bio Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2017. The company has been dissolved on 24 July 2026. The company was registered under the industry Detailhandel med andre nye varer. The company was previously named H. C. Andersen Emeren Group ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,673 compared with DKK -20,418 the year before. Equity in the 2025 report amounted to DKK -312,718.